DPSCs-Exos promote OPCs differentiation and white matter repair via Myl9-mediated PRMT5 nucleation after ischemic stroke
Journal of Cerebral Blood Flow & Metabolism · 2026
DOI: 10.1177/0271678x251399014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cerebral Blood Flow & Metabolism, 2026. Verfasst von Weihong Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, School of Basic Medical Sciences, Advanced Innovation Center for Human Brain Protection, Capital Medical Univ…. Hauptthemen laut MEDLINE: White Matter, Ischemic Stroke, Protein-Arginine N-Methyltransferases, Exosomes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke often leads to white matter damage due to impaired oligodendrocyte precursor cells (OPCs) differentiation, hindering post-stroke recovery. While dental pulp stem cells-derived exosomes (DPSCs-Exos) have shown promise in stroke recovery, the underlying mechanisms remain unclear. Toward this aim, we investigated the therapeutic potential of DPSCs-Exos for promoting OPCs differentiation and white matter repair after ischemic stroke using in vivo (middle cerebral artery occlusion, MCAO) and in vitro (oxygen-glucose deprivation/reoxygenation, OGD/R) models. Intracerebroventricular DPSCs-Exos were administered on days 1, 3, and 5 post-MCAO, with functional (sensory-motor and cognitive), morphological, and biochemical assessments performed at 7, 14, and 28 days. Our results demonstrated that DPSC-Exos treatment significantly improved functional outcomes, promoted OPCs proliferation and differentiation, and facilitated white matter repair. Mechanistically, DPSC-Exos-mediated OPCs differentiation involves protein arginine methyltransferase 5 (PRMT5) and inhibitor of differentiation 2 (ID2). Specifically, exosomal myosin regulatory light polypeptide 9 (Myl9) interacts with PRMT5 in OPCs, driving PRMT5 nucleation, subsequent CpG island methylation, and ID2 downregulation, ultimately leading to OPCs differentiation into oligodendrocytes (OLs). These findings identify a novel mechanism by which DPSC-Exos promote white matter repair and suggest their potential as a therapeutic strategy for ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, School of Basic Medical Sciences, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
- Department of Biochemistry and Molecular Biology, Capital Medical University, Beijing, China.
- Institute of Neuroscience, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Beijing SH Biotech Corporation, Beijing, China.
- School of Biosciences, University of Sheffield, Sheffield, UK.
ORCID-Profile: Chun Guo, Xinchun Jin
Zitieren
APA
Du, W., Geng, P., Lian, Z., Sun, Y., Zhou, Y., Guo, C., & Jin, X. (2026). DPSCs-Exos promote OPCs differentiation and white matter repair via Myl9-mediated PRMT5 nucleation after ischemic stroke. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x251399014
Vancouver
Du W, Geng P, Lian Z, Sun Y, Zhou Y, Guo C, et al. DPSCs-Exos promote OPCs differentiation and white matter repair via Myl9-mediated PRMT5 nucleation after ischemic stroke. Journal of Cerebral Blood Flow & Metabolism. 2026. doi:10.1177/0271678x251399014
BibTeX
@article{Du2026,
author = {Du, Weihong and Geng, Panpan and Lian, Zheng and Sun, Yanyun and Zhou, Yong and Guo, Chun and Jin, Xinchun},
title = {DPSCs-Exos promote OPCs differentiation and white matter repair via Myl9-mediated PRMT5 nucleation after ischemic stroke},
journal = {Journal of Cerebral Blood Flow & Metabolism},
year = {2026},
doi = {10.1177/0271678x251399014}
}
EUVIMED